Australian Clinical Labs Limited (ASX:ACL) Announces Interim Dividend of $0.04

Australian Clinical Labs Limited (ASX:ACL) declared a interim dividend on Thursday, February 27th, MarketIndexAU Dividends reports. Stockholders of record on Tuesday, April 15th will be paid a dividend of 0.035 per share on Tuesday, April 15th. This represents a dividend yield of 1.07%. The ex-dividend date of this dividend is Wednesday, March 26th. This is an increase from Australian Clinical Labs’s previous interim dividend of $0.03.

Australian Clinical Labs Stock Performance

The firm has a market cap of $728.27 million, a P/E ratio of 30.38, a price-to-earnings-growth ratio of -0.36 and a beta of 1.18. The company has a current ratio of 0.64, a quick ratio of 0.53 and a debt-to-equity ratio of 174.00.

Australian Clinical Labs Company Profile

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services.